← Leaderboards
Bingfa Sun
Confometrx, Inc.
$4,003,184
Attributed
$9,424,322
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,424,322 · 6
By mechanism
R44$6,158,634 · 3
UG3$2,664,000 · 1
R43$601,688 · 2
Top collaborators
- Inbar Fish8 shared
- Dan Feng5 shared
- Victoria Ahn3 shared
- Matthew Chu1 shared
- Brian K Kobilka1 shared
- Susruta Majumdar1 shared
- Jay P Mclaughlin1 shared
Most similar at Confometrx, Inc.
Same institution · by research overlap
- Inbar Fish$1,649,318
- Dan Feng$2,524,550
- Victoria Ahn$817,454
- Matthew Chu$124,502
Others in their field
Top investigators on “Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,487,925
- David Heimbrook · Leidos Biomedical Research, Inc.$277,323,479
- Richard A Gibbs · Baylor College Of Medicine$249,395,936
- David R. Weir · University Of Michigan At Ann Arbor$236,797,614
- Peter B. Gilbert · Fred Hutchinson Cancer Center$153,633,436
- Ralph Parchment · Leidos Biomedical Research, Inc.$135,017,102
Research focus
ScreeningSmall MoleculeStructureAgonistG-Protein-Coupled ReceptorsResolutionResponsePharmaceutical PreparationsLeadDesignBindingLigandsClinical TrialsDrug DiscoveryBasePharmacologic SubstanceReceptorInsightSide EffectSmall Business Innovation Research GrantAffinityMolecular ConformationBrainAdverse Effects
Grant awards (14)
Development of negative allosteric modulators at the mu opioid receptor$2,664,000
UG3 · FY2025 · DA
Discovery of GPR75 small molecule ligands for the treatment of obesity$303,375
R43 · FY2023 · DK · contact PI
Discovery of GPR171 small molecule ligands for the treatment of chronic pain$298,313
R43 · FY2023 · NS · contact PI
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands$738,119
R44 · FY2021 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$676,062
R44 · FY2021 · MH · contact PI
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands$764,531
R44 · FY2020 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$676,062
R44 · FY2020 · MH · contact PI
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$676,062
R44 · FY2019 · MH · contact PI
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands$659,183
R44 · FY2019 · MH
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$381,468
R44 · FY2018 · MH · contact PI
Structure-based Drug Discovery for the GLP-1 Receptor$494,338
R44 · FY2017 · DK · contact PI
Structure-based discovery of dopamine D1 receptor selective small molecule ligands$376,468
R44 · FY2017 · MH · contact PI
Structure-based Drug Discovery for the GLP-1 Receptor$467,338
R44 · FY2016 · DK · contact PI
Structure-based Drug Discovery for the GLP-1 Receptor$249,003
R44 · FY2015 · DK